Revium Rx (RVRC) Short term Debt (2024 - 2025)
Revium Rx's (RVRC) quarterly Short term Debt came in at $575000.0 in Q4 2025, up 164.98% year-on-year from $217000.0 in Q4 2024, and up 164.98% quarter-over-quarter from $217000.0 in Q4 2024.
Revium Rx (RVRC) Short term Debt (2024 - 2025) Analysis & Trends
Revium Rx has disclosed Short term Debt across 2 years of filings, most recently posting $575000.0 for Q4 2025.
- Short term Debt for Q4 2025 came in at $575000.0, up 164.98% year-over-year; the trailing twelve-month figure through Dec 2025 was $575000.0 (up 164.98% YoY), and the FY2025 annual result was $575000.0, up 164.98% from the prior year.
- Short term Debt came in at $575000.0 for Q4 2025 at Revium Rx, up from $217000.0 in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $575000.0 in Q4 2025 to a low of $217000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn |
| 10 | Revium Rx | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 575,000.00 |
| Dec 31, 2024 | 217,000.00 |